Study: GAL-001: Adaptive Phase II in Refractory Melanoma
Phase II
· Site: St. Brigid University Hospital (Dr. C. Nolan)
· consented 2026-08-06
Adverse events
0
Serious AEs
0
Open data queries
0
Luna dropout signal
+0.0
Adverse events
No adverse events recorded.
Data queries
No data queries.
☾ Luna engagement
Messages
0
Escalations
0
Check-ins
0
Mood ø
–
Med adherence · 7d
–
Last check-in
–